Three Democrat reps oppose Medicare drug pricing plan; Alpine Immune announces private placement
A trio of key Democrats said yesterday they will oppose their party’s plan to lower drug prices — creating a substantial roadblock for the Democrats’ — and the White House’s — desired $3.5 trillion tax and spending package.
According to the Washington Post, Reps. Scott Peters (D-Calif.), Kathleen Rice (D-N.Y.) and Kurt Schrader (D-Ore.) have concerns about giving Medicare the authority to negotiate directly with drug companies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.